SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008066
Filing Date
2019-08-13
Accepted
2019-08-13 16:19:54
Documents
105
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zcor-20190630x10q.htm 10-Q 3566415
2 EX-10.1 zcor-20190630ex101f54b37.htm EX-10.1 80205
3 EX-10.2 zcor-20190630ex102dd7a25.htm EX-10.2 85603
4 EX-31.1 zcor-20190630ex311368f80.htm EX-31.1 17372
5 EX-32.1 zcor-20190630ex32117f535.htm EX-32.1 8925
  Complete submission text file 0001558370-19-008066.txt   15118272

Data Files

Seq Description Document Type Size
6 EX-101.INS zcor-20190630.xml EX-101.INS 3732196
7 EX-101.SCH zcor-20190630.xsd EX-101.SCH 93944
8 EX-101.CAL zcor-20190630_cal.xml EX-101.CAL 91376
9 EX-101.DEF zcor-20190630_def.xml EX-101.DEF 461935
10 EX-101.LAB zcor-20190630_lab.xml EX-101.LAB 720706
11 EX-101.PRE zcor-20190630_pre.xml EX-101.PRE 665642
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 191020878
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1